9th & 10th July 1996
The Second International Conference on:
Pharmaceuticals and Healthcare in the Central Asian States of the Former Soviet Union and the Caucasian Republics
The Renaissance Hotel, Instanbul
09.15 Welcome Address by Chairman: Mr R T Sultanov, First Deputy Minister of Health, Ministry of Health, Uzbekistan
Session One: Current situation in the healthcare/pharmaceutical sector in the Central Asian and Caucasian States of the FSU. Steps taken by Governments towards healthcare reforms.
Mr H Cetin, Former Minister, Ministry of Foreign Affairs, Turkey
Mr R Sultanov First Deputy Minister of Health, Ministry of Health, Uzbekistan
Mr M Kulzhanov, Deputy Minister of Health, Ministry of Health, Kazakhstan
Mr Diorbenadze, Minister of Health, Ministry of Health, Georgia
11.00 SessionTwo: The privatisation process in the health care sector.
Mr A Grigoryan, Deputy Minister of Health, Ministry of Health, Armenia
Mr R Eshmanbetov, Deputy Chairman of the Board, State Property Fund, Kyrghyzstan
Ms Z Khuseinova, Deputy Minister of Health, Ministry of Health, Azerbaijan
13.45 SessionThree: Financing the health care sector. Health Insurance.
Mr I Dzholdubaev, Deputy Minister, Ministry of Health, Kyrghyzstan
Mr T Imanbaev, President, National Health Insurance Fund, Kazakhstan
Mr D Broun, Healthcare Specialist, the World Bank, Washington*
Mr A Kilicoglu, Deputy GeneraI Manager, Turk EXIM Bank, Turkey
Ms C Phillips, Principal banker, Kazakhstan & Uzbekistan Department, EBRD, London*
15.00 Session Four: The climate for investments in the region
Mr C Brunner, Marketing Director, Pharmadule AB & Pharmacia, Sweden
Mr Sh Karimov, Chairman of the Board, UzbekHoechst Pharma, Uzbekistan
Mr A Kejdiwal, General Director, Ajanta Pharma, India*
16.15 Session Five: Legislation.affecting the pharmaceutical sector; registration procedures
Mr Abdrakhmanov, General Director, Quality Control Committee, Kazakhstan
Mr U Zakirov, Chairman, Pharmacological Committee, Uzbekistan
Mr A Evans, Partner, Clifford Chance, Moscow*
17.45 Cocktail Party
09.00 Session One Development of the local and regional pharmaceutical industry
Mr S Asatov, General Director, Uzkhimpharm,Uzbekistan
Mr T Rakishev, General Director, Romat, Semipalatinsk, Kazakhstan
Mr B Tokochev, General Director, Biopharm, Kyrghyzstan
10.00 SessionTwo: Establishing distribution networks.
Ms Karieva, President, Dzhurabek, Uzbekistan
Ms G Aitkhozhina, General Director, Iske Set, Kazakhstan
Mr Cholponbaev, General Director, Pharmimpex, Kyrghyzstan
Mr A Abayev, General Director, Turkmenpharmacia, Turlmenistan
11.30 Session Three: Choosing the right marketing and promotional strategy in the area
Mr N Derbil, Export Manager, Sandoz Urunleri, Turkey
Mr R Musneci, General Manager for Ukraine, Kazakhstan, Uzbekistan, Slovenia, Croatia, Macedonia, Serbia and Central Asia, Glaxo-Wellcome, London
Mr Z Yazan, Export Manager, Eczacibasi, Turkey
14.15 Session Four: Parallel sessions: OTC/Medical Equipment Market.
Workshop A: OTC Products.
Ms A Battaglini, Regional Manager, Berlin-Chemie, Germany*
Dr Arndt, Head of the Pharmaceutical Division, Bayer, Moscow*
Prof. G Vakhidova, Medical Marketing Director, Director-Uzbekistan, Boehringer Ingelheim, Uzbekistan
Workshop B: Medical Equipment
Dr G Abedin, Head of Department, Medical Equipment, Siemens, Uzbekistan
Mr A Khalimon, Sales Manager, Central Asian region, General Electrics, Moscow
15.45 Session Five: Regional Case Studies. Problems and Solutions.
Mr C Colakoglu, Area Manager, Central Asia, Kazakhstan, and Azerbaijan, Eli Lilly Suisse, Kazakhstan
Mr Belgener, Head of Representation office, Sanavita, Turkey
Mr G Lifshits, Head of Representation office, CPH, Moscow
16.15 Final Plenary Session: Speakers from earlier sessions will join in an extensive question and answer discussion between the panel and the audience
16.45 Approximate close of the conference
Leading partners from prominent western advising and consulting groups will join the industry and governmental speakers in many sessions.
Booking & Administration Details
Adam Smith Contact Information | Return to the Central Lobby | Return to Conference Index
© Adam Smith Institute